Published on 14 Nov 2022 on Zacks via Yahoo Finance
Onconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates
Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -23.81%. A quarter ago, it was expected that this company would post a loss of $0.20 per share when it actually produced a loss of $0.19, delivering a surprise of 5%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.